173 IN VIVO CHARACTERISATION OF THE NEW SELECTIVE SIGMA‐1 RECEPTOR ANTAGONIST (S1RA): POTENTIAL USE FOR THE TREATMENT OF NEUROPATHIC PAIN | Publicación